Provided by Tiger Fintech (Singapore) Pte. Ltd.

Becton Dickinson

167.95
+0.81000.48%
Post-market: 168.490.5400+0.32%19:43 EDT
Volume:4.31M
Turnover:727.06M
Market Cap:48.14B
PE:32.53
High:170.49
Open:167.14
Low:166.13
Close:167.14
Loading ...

Insider Moves: Becton Dickinson Director Cashes In on Stock Sale!

TIPRANKS
·
13 Feb

Becton Dickinson & Co. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
13 Feb

Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term

Zacks
·
12 Feb

Becton Dickinson Director Makes Bold Stock Purchase

TIPRANKS
·
11 Feb

Becton Dickinson director buys $350.4K in common stock

TIPRANKS
·
11 Feb

Exxon Mobil Corp: A Significant Reduction in First Eagle Investment's Portfolio

GuruFocus.com
·
11 Feb

Citi Sticks to Its Buy Rating for Becton Dickinson (BDX)

TIPRANKS
·
10 Feb

When Will BCAL Diagnostics Limited (ASX:BDX) Turn A Profit?

Simply Wall St.
·
10 Feb

Becton Dickinson First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
07 Feb

Becton Dickinson & Co (BDX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
07 Feb

Q1 2025 Becton Dickinson and Co Earnings Call

Thomson Reuters StreetEvents
·
07 Feb

Becton Dickinson Reports Strong Q1 Financial Results

TIPRANKS
·
07 Feb

Wells Fargo Adjusts Becton, Dickinson Price Target to $270 From $275

MT Newswires Live
·
07 Feb

Becton Dickinson to Separate Biosciences and Diagnostic Solutions Business

GuruFocus.com
·
07 Feb

Stock Track | Becton Dickinson Plummets 5.43% as Separation Plan and Guidance Cut Disappoint Investors

Stock Track
·
07 Feb

BD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin Up

Zacks
·
07 Feb

FDA: Aware That Bard Peripheral Vascular Issued Letter to Affected Customers Giving Updated Instructions for Use for Rotarex Atherectomy Systems

THOMSON REUTERS
·
07 Feb

FDA: Bd Reported 30 Serious Injuries & 4 Deaths Associated With Atherectomy Catheter System Issue From Bard Peripheral Vascular

THOMSON REUTERS
·
07 Feb

Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business

Benzinga
·
06 Feb

Becton Shares Down 3.6% After Q1 Results

THOMSON REUTERS
·
06 Feb